Contract Development and Manufacturing Organizations (CDMOs) play a pivotal role in bringing modern pharmaceutical innovations to market efficiently. DCM PHARMA GMBH offers comprehensive CDMO services to biotechnology firms, generic pharmaceutical companies, and brand-name drug developers. Operating flexible, GMP-certified production facilities in Austria, we manage every phase of the manufacturing lifecycle—from lab-scale formulation development and clinical trial batch production to full-scale commercial manufacturing and automated packaging.

Our engineering and pharmaceutical formulation teams possess extensive technical expertise in oral solid dosage forms (tablets, film-coated tablets, capsules), sterile liquid fills, topical formulations, and specialized chemical synthesis. By combining state-of-the-art cleanroom technology with rigorous quality oversight, DCM PHARMA enables clients to accelerate time-to-market while reducing capital expenditure.

“From formulation optimization to full commercial packaging, DCM PHARMA CDMO services provide flexible, high-capacity pharmaceutical manufacturing with absolute IP security.”

Formulation Development & Clinical Trial Supply

DCM PHARMA’s CDMO workflow begins in our dedicated formulation development laboratories. Our formulation scientists work collaboratively with client R&D teams to optimize drug delivery, enhance bioavailability, establish robust granulating processes, and select compatible excipients. We perform pre-formulation screening, solubility studies, and stress testing to establish stable, scalable manufacturing formulas.

For early-phase development, DCM PHARMA produces pilot-scale and clinical trial batches (Phase I to Phase III) under full GMP compliance. Our flexible manufacturing suites accommodate small batch sizes required for investigational medicinal products (IMPs), complete with specialized primary packaging, labeling, and blinding for clinical distribution.

Commercial Production & Cleanroom Packaging

Transitioning to commercial scale is seamless with DCM PHARMA’s high-capacity manufacturing lines. Our production facility houses automated high-speed tablet presses, encapsulation machines, fluid-bed granulators, and film-coating pans operating within ISO Class 7 (Grade C) cleanroom environments. Automated in-line weight check-weighers, hardness testers, and friability analyzers verify product specifications continuously during compression.

Our primary and secondary packaging capabilities include high-speed thermoform and cold-form blister packing (Alu/Alu, PVC/PVDC), bottle filling lines, cartoners, serialization equipment, and tamper-evident sealing. We support European Union Falsified Medicines Directive (EU FMD) serialization requirements with 2D DataMatrix code printing and aggregation reporting.

Quality Management & Intellectual Property Protection

Protecting our client’s intellectual property is fundamental to our contract manufacturing philosophy. DCM PHARMA operates under strict confidentiality protocols and dedicated project management. Client projects are assigned dedicated cross-functional teams comprising technical transfer specialists, analytical chemists, quality managers, and regulatory advisors.

Our manufacturing operations undergo regular audits by European regulatory authorities and client quality teams. With full batch traceability, process validation (PV) protocols, and real-time environmental monitoring, DCM PHARMA delivers contract manufacturing excellence tailored to international commercial standards.